Crxt sec filings
WebCRXT SEC Filings - Clarus Therapeutics Holdings Inc - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must … WebSep 15, 2024 · About SEC Filings Nasdaq provides company’s SEC filings , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia.
Crxt sec filings
Did you know?
WebCRXT SEC Filings - Clarus Therapeutics Holdings Inc - Annual Report, Proxy Statement, Prospectus. ... SEC Full-Text Search Latest S-1 (IPO) Filings Latest S-3 Filings Latest … WebMay 24, 2024 · Filing Detail. SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page; Form S-1 - General form for registration of securities under the Securities Act of 1933: SEC Accession No. 0001193125-22-158662 ... crxt-20240331.xsd: EX-101.SCH: 93484: 5: XBRL TAXONOMY EXTENSION …
WebCRXT similar filings. 14 Dec 21 Clarus Therapeutics / Steven A. Bourne ownership change; ... options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) WebApr 25, 2024 · Clarus Therapeutics Holdings ( NASDAQ: CRXT) is down 22% in premarket trading after the company filed for an equity offering with the SEC. The offering is for just over 12M units that consist of ...
WebWe present 13D/G filings separately from the 13F filings because of the different treatement by the SEC. 13D/G filings can be filed by groups of investors (with one leading), whereas 13F filings cannot. This results in … WebClarus Therapeutics Holdings Inc. SEC filings breakout by MarketWatch. View the CRXT U.S. Securities and Exchange Commission reporting information.
WebFebruary 1, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendment Filing. January 31, 2024 - 10-K: Annual report for year ending December 31, 2024 Filing. January 25, 2024 - 8-K: Current report Filing **Earnings release**. 1.01 - Entry into a Material Definitive Agreement.
WebAbout SEC Filings Nasdaq provides company’s SEC filings , which are financial statements and reports filed electronically with the U.S. Securities and Exchange … homes for sale in navarre beach fl zillowWebSEC Filings CRA International Inc. homes for sale in navasota tx 77868WebIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes homes for sale in navasota texasWebDec 31, 2024 · SEC Form U-13-1: An application that doubles as both a request for approval by the Securities and Exchange Commission (SEC) for any mutual service company, or a declaration of organization and ... hip surgery diagnosis codeWebMar 30, 2024 · Clarus Therapeutics Holdings, Inc. (CRXT) SEC Filing 8-K Material Event for the period ending Wednesday, March 30, 2024. Home. SEC Filings. Clarus Therapeutics Holdings, Inc. (CRXT) 8-K Material Event Wed Mar 30 2024; SEC Filings. CRXT Valuations. Intrinsic Value. Financial Stability. Financial Ratios. homes for sale in nazareWebDaily Brief Latest News Macro Industry Macro Country ETF Database Mutual Fund Database Industry Explorer SEC Forms Finpedia Latest S1 (IPO) Filings Latest 13D/G Filings Latest 13F Filings. Portfolio Builder / Fund Intersect. hip surgery death rateWebMay 9, 2024 · Latest SEC filings for Clarus Therapeutics Holdings, Inc. (CRXTQ). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … homes for sale in nazareth school district